Zobrazeno 1 - 10
of 249
pro vyhledávání: '"Emminger W."'
Autor:
van Straalen JW, Kearsley-Fleet L, Klotsche J, de Roock S, Minden K, Heiligenhaus A, Hyrich KL, de Boer JH, Lamot L, Olivieri AN, Gallizzi R, Smolewska E, Faugier E, Pastore S, Hashkes PJ, Herrera CN, Emminger W, Consolini R, Wulffraat NM, Ruperto N, Swart JF, Paediatric Rheumatology International Trials Organisation (PRINTO), UK CAPS study, and German ICON study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3977::fc076878b7e23600d1d30d095776d268
https://hdl.handle.net/11591/485618
https://hdl.handle.net/11591/485618
Autor:
Sengler, C, Eulert, S, Minden, K, Niewerth, M, Horneff, G, Kümmerle-Deschner, J, Siemer, C, Berendes, R, Girschick, HJ, Hühn, R, Borte, M, Hospach, A, Emminger, W, Armann, J, Klein, A, Kallinich, T
Publikováno v:
Deutscher Rheumatologiekongress 2021, 49. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 35. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh), Wissenschaftliche Herbsttagung der Gesellschaft für Kinder-und Jugendrheumatologie (GKJR); 20210915-20210918; sine loco [digital]; DOCCO.03 /20210914/
Einleitung: Obwohl Kinder und Jugendliche seltener und milder an COVID-19 erkranken als Erwachsene, ist unklar, welchen Einfluss die SARS-CoV-2-Infektion auf juvenile Patienten mit rheumatischen Erkrankungen hat. Aufgrund ihrer Grunderkrankung sowie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beef0117fd643ab11c4924ee22a165fe
Autor:
Giancane G1, Swart JF2, Castagnola E3, Groll AH4, Horneff G5, 6, Huppertz HI7, Lovell DJ8, Wolfs T2, Herlin T9, Dolezalova P10, Sanner H11, Susic G13, Sztajnbok F14, Maritsi D15, Constantin T16, Vargova V17, Sawhney S18, Rygg M19, K Oliveira S21, Cattalini M22, Bovis F1, Bagnasco F1, Pistorio A23, Martini A24, Wulffraat N2, Ruperto N25, Paediatric Rheumatology International Trials Organisation (PRINTO). Cuttica R, Garay SM, Brunner J, Emminger W, Appenzeller S, Len C, Saad Magalhaes C, Telcharova-Mihaylovska A, Harjacek M, Jelusic M, Estmann A, Nielsen S, Herrera Mora C, Gervais E, Koné-Paut I, Quartier P, Foeldvari I, Horneff G, Lutz T, Minden K, Tzaribachev N, Trachana M, Tsitsami E, Vougiouka O, Orban I, Harel L, Hashkes P, Uziel Y, Cimaz R, Civino A, Consolini R, D'Angelo G, De Benedetti F, Filocamo G, Fueri E, Gallizzi R, Maggio MC, Magnolia MG, Miniaci A, Montin D, Olivieri A. N., Pastore S, Rigante D, Zulian F, Rumba-Rozenfelde I, Stanevicha V, Panaviene V, Rodriguez Lozano AL, Rubio-Perez N, Vega Cornejo G, Hoppenreijs E, Kamphuis S, Flato B, Nordal EB, Abdwani R, Miraval T, Paz Gastanaga ME, Smolewska E, Ailioaie C, Cochino AV, Laday M, Lazar C, Alexeeva E, Chasnyk V, Keltsev V, Suwairi WMS, Vijatov-Djuric G, Vojinovic J, Arkachaisri T, Koskova E, Avcin T, Ally M, Van Rensburg CJ, Louw I, Lopez JA, Boteanu AL, Calvo Penades I, De Inocencio J, Mesa-Del-Castillo P, Moreno E, Remesal A, Hofer M, Gok F, Ozen S, Ramanan A, Pallotti C, Villa L.
Publikováno v:
Giancane, G, Swart, J F, Castagnola, E, Groll, A H, Horneff, G, Huppertz, H-I, Lovell, D J, Wolfs, T, Dolezalova, P, Sanner, H, Susic, G, Sztajnbok, F, Maritsi, D, Constantin, T, Vargova, V, Sawhney, S, Rygg, M, K Oliveira, S, Cattalini, M, Bovis, F, Bagnasco, F, Pistorio, A, Martini, A, Wulffraat, N, Ruperto, N & Paediatric Rheumatology International Trials Organisation (PRINTO) 2020, ' Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis : analysis by the Pharmachild Safety Adjudication Committee ', Arthritis Research & Therapy, vol. 22, no. 1, 71 . https://doi.org/10.1186/s13075-020-02167-2
Arthritis Research & Therapy
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-15 (2020)
Arthritis Research and Therapy, 22(1):71. BioMed Central Ltd.
Arthritis Research & Therapy
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-15 (2020)
Arthritis Research and Therapy, 22(1):71. BioMed Central Ltd.
Background: To derive a list of opportunistic infections (OI) through the analysis of the juvenile idiopathic arthritis (JIA) patients in the Pharmachild registry by an independent Safety Adjudication Committee (SAC). Methods: The SAC (3 pediatric rh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec9e6cd75a25aa92f68a51d2cdd36e18
https://doi.org/10.1186/s13075-020-02167-2
https://doi.org/10.1186/s13075-020-02167-2
Autor:
R. Hühn, S. Eulert, G. Horneff, H. Girschick, Tilmann Kallinich, Michael Borte, Rainer Berendes, Emminger W, Ariane Klein, Siemer C, Claudia Sengler, Jasmin B Kuemmerle-Deschner, Martina Niewerth, K. Minden, A. Hospach, Jakob Peter Armann
ObjectivesDue to their underlying disease as well as therapeutic immunosuppression, children and adolescents with rheumatic and musculoskeletal diseases (RMD) may be at higher risk for a severe course or worse outcome of COVID-19, and SARS-CoV2 infec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db86a35bd53d873363ea4d29ea130a84
https://doi.org/10.1101/2021.03.28.21254496
https://doi.org/10.1101/2021.03.28.21254496
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 9, Iss Suppl 1, p P259 (2011)
Externí odkaz:
https://doaj.org/article/3fba085577b14f809900c6d55238b058
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 9, Iss Suppl 1, p P70 (2011)
Externí odkaz:
https://doaj.org/article/3466102937e444689e88c94178200527
Autor:
Brachat A. H., Grom A. A., Wulffraat N., Brunner H. I., Quartier P., Brik R., McCann L., Ozdogan H., Rutkowska-Sak L., Schneider R., Gerloni V., Harel L., Terreri M., Houghton K., Joos R., Kingsbury D., Lopez-Benitez J. M., Bek S., Schumacher M., Valentin M. -A., Gram H., Abrams K., Martini A., Lovell D. J., Nirmala N. R., Ruperto N., Cuttica R., Emminger W., Lauwerys B., Wouters C., Goffin L., Sztajnbok F., Radominski S., Oliveira S., Haddad E., Kone-Paut I., Desjonqueres M., Fischbach M., Thon A., Foell D., Weibarth-Riedel E., Horneff G., Trauzeddel R., Berner R., Kallinich T., Trachana M., Constantin T., Barash J., Berkun Y., Uziel Y., Corona F., Alessio M., Cimaz R., Viola S., Flato B., Ferrandiz M., Calvo I., Anton J., Robledillos J. C., Gamir M. L., Magnusson B., Hofer M., Unsal E., Erguven M., Ozen S., Wilkinson N., Chieng A., Ramanan A., Foster H., Nistala K., Higgins G., Marzan K., Schikler K., Morris P.
Publikováno v:
Arthritis Research & Therapy, 19(1). BioMed Central
Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
Arthritis Research & Therapy
Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
Arthritis Research & Therapy
Novartis Pharma Background: Canakinumab is a human anti-interleukin-1 beta (IL-1 beta) monoclonal antibody neutralizing IL-1 beta-mediated pathways. We sought to characterize the molecular response to canakinumab and evaluate potential markers of res
Autor:
Quartier, Pierre, Alexeeva, Ekaterina, Constantin, Tamàs, Chasnyk, Vyacheslav, Wulffraat, Nico, Palmblad, Karin, Wouters, Carine, I. Brunner, Hermine, Marzan, Katherine, Schneider, Rayfel, Horneff, Gerd, Martini, Alberto, Anton, Jordi, Wei, Xiaoling, Slade, Alan, Ruperto, Nicolino, Abrams, Ken, Emminger, W., Ulbrich, A., Fodor, S.
Publikováno v:
Arthritis & Rheumatology; Feb2021, Vol. 73 Issue 2, p336-346, 11p
Autor:
Emminger, W., Hernández, M.D., Cardona, V., Smeenk, F., Fogh, B.S., Calderon, M.A., De Blay, F., Backer, V.
Background: The SQ house dust mite (HDM) SLIT-tablet (ALK, Denmark) addresses the underlying cause of HDM respiratory allergic disease, and a clinical effect has been demonstrated for both HDM allergic rhinitis and allergic asthma. Here, we present p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfa13bb07a0c0e51838b2fa7878631f3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.